Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease

In summary, our data suggest that guanabenz and other GADD34 inhibitors could be used as therapeutic agents to boost parkin levels and thereby slow neurodegeneration in PD and other neurodegenerative conditions.